Stručni rad - Pismo uredniku
Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms
Journal of Thrombosis and Thrombolysis, 55 (2023), 4; 760-761. https://doi.org/10.1007/s11239-023-02779-w

Lucijanic, Marko; Krečak, Ivan

Citirajte ovaj rad

Lucijanic, M. i Krečak, I. (2023). Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms. Journal of Thrombosis and Thrombolysis, 55. (4), 760-761. doi: 10.1007/s11239-023-02779-w

Lucijanic, Marko i Ivan Krečak. "Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms." Journal of Thrombosis and Thrombolysis, vol. 55, br. 4, 2023, str. 760-761. https://doi.org/10.1007/s11239-023-02779-w

Lucijanic, Marko i Ivan Krečak. "Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms." Journal of Thrombosis and Thrombolysis 55, br. 4 (2023): 760-761. https://doi.org/10.1007/s11239-023-02779-w

Lucijanic, M. i Krečak, I. (2023) 'Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms', Journal of Thrombosis and Thrombolysis, 55(4), str. 760-761. doi: 10.1007/s11239-023-02779-w

Lucijanic M, Krečak I. Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms. Journal of Thrombosis and Thrombolysis [Internet]. 06.02.2023. [pristupljeno 13.07.2024.];55(4):760-761. doi: 10.1007/s11239-023-02779-w

M. Lucijanic i I. Krečak, "Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms", Journal of Thrombosis and Thrombolysis, vol. 55, br. 4, str. 760-761, Veljača 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:890614. [Citirano: 13.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.